secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2021-11-22T23:59:59+00:00
Accession:  0001558370-21-016275
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences appoints Linda Szyper to Board of Directors
---------------------------------------------------------------

- Linda Szyper, former COO of McCann Health, appointed as Class II director effective Nov 18, 2021.
- She fills vacancy created by resignation of Eric L. Motley in August 2021.
- Will serve on the Nominating and Corporate Governance Committee; deemed independent under Nasdaq.
- Over 30 years experience in pharma marketing, commercialization, and healthcare communications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/0001558370-21-016275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/hrmy-20211118x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-016275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer